This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thousands Convene At The Washington Monument For The Epilepsy Foundation's Annual National Walk For Epilepsy

WASHINGTON, April 20, 2013 /PRNewswire/ -- The Epilepsy Foundation announced today that thousands of people have assembled at the Washington Monument grounds this morning for a three-mile walk in support of those who face the challenges of living with epilepsy and seizures, and to drive funding that will accelerate therapeutic advancement and grow awareness of this potentially life-threatening disease.  With a pre-walk rally at 8:30 a.m., the walk kicks off at 9:00 a.m. and post-walk festivities run through noon today.

Actor Greg Grunberg of the television series Heroes and his son Jake; Geoffrey Pope, former New York Giants cornerback; and Tony Coelho, former U.S. Congressman from California and primary author of the Americans with Disabilities Act, are among those supporting the walk, and can speak personally based on their experiences with epilepsy.

During the walk, a number of participants will be tweeting updates and stories, including Greg Grunberg, @GregGrunberg and the Epilepsy Foundation @EpilepsyFDN.  People with epilepsy are invited to join the conversation. Photos and information on the event also will be available on Facebook: https://www.facebook.com/EpilepsyFoundationofAmerica.

"We are grateful for the extraordinary support we are receiving from families, physicians, researchers, government and industry today in Washington, D.C.," said Philip M. Gattone, President and CEO of the Epilepsy Foundation.  "The Epilepsy Foundation is dedicated to improving the lives of people with epilepsy and seizures by finding new therapies for this potentially life-threatening and broad-spread condition.  Seizures and the diagnosis of epilepsy can affect anyone, and is now known to occur with traumatic brain injury, autism, Parkinson's disease and other neurological disorders, as well as for returning veterans of war.  The Epilepsy Foundation has contributed to the advancement of more than 40 seizure management therapies, some of which are now available.  Yet, there's still much to accomplish when one-third of people with epilepsy live with uncontrolled seizures and many more live with unacceptable side effects from their medications."

More than 2 million people in the U.S., including 80,000 people in the Washington, D.C. metropolitan area, are living with epilepsy and seizures.  One in 26 Americans will develop epilepsy during their lifetimes.  Epilepsy—a medical condition characterized by recurring seizures—can affect anyone, of any age, at any time.

To learn more about the walk or contribute to a team, please visit:  www.walkforepilepsy.org.   

About Epilepsy

When a person has two or more unprovoked seizures, they have epilepsy, which affects nearly three million people in the United States and 65 million people worldwide. This year, another 200,000 people in our country will be diagnosed with epilepsy.  Despite all available treatments, 30 to 40 percent of people with epilepsy continue to experience uncontrolled seizures while many more experience less than optimal seizure control.   



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,544.55 +144.88 0.88%
S&P 500 1,931.08 +27.07 1.42%
NASDAQ 4,389.22 +73.1460 1.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs